If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

Vaccinations for Covid-19 are now underway in the U.S. Two vaccines – one from Pfizer and BioNTech, one from Moderna — have ...

The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns ...

Research teams across Canada are now building on homegrown innovation to expand the potential of RNA vaccines beyond ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...

The company disclosed revenue of $13.7 billion and adjusted earnings of $0.92 per share, compared to consensus estimates of ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.